AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pawellek, A.
Right arrow Articles by Weber, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pawellek, A.
Right arrow Articles by Weber, O.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2001, p. 1014-1021, Vol. 45, No. 4
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.4.1014-1021.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Xenograft Model for Identifying Chemotherapeutic Agents against Papillomaviruses

A. Pawellek,1 G. Hewlett,1,* J. Kreuter,2 H. Rübsamen-Waigmann,1 and O. Weber1

PH-R Ai2 Virology, Bayer AG, Wuppertal,1 and Institut für Pharmazeutische Technologie, Universität Frankfurt am Main, Frankfurt am Main,2 Germany

Received 27 July 2000/Returned for modification 30 November 2000/Accepted 3 January 2001

The report describes the establishment and characterization of a mouse xenograft transplantation model for the study of papillomavirus infection of bovine skin. Calf scrotal skin was inoculated with bovine papillomavirus type 2 before grafting it to the dorsum of severe combined immunodeficient mice. The grafted skin contained epidermis, dermis, and a thin layer of fat. After 5 months the induced warts not only showed histological features of papillomavirus infections but also tested positive for viral DNA and papillomavirus capsid antigen. The formation of infectious virions was demonstrated by inoculation of new transplants with crude extract from the induced warts as well as in a cell culture focus assay. Topical application of bromovinyl-2'-deoxyuridine led to a reduction in viral DNA content in the developing wart. This small-animal xenograft model should be useful for characterizing antiviral compounds and providing an understanding of the regulation of papillomavirus infections.


* Corresponding author. Mailing address: Bayer AG, PH-R Ai2, P.O. Box 101709, 42096 Wuppertal, Germany. Phone: 49-202-368411. Fax: 49-202-364162. E-mail: guy.hewlett.gh{at}bayer-ag.de.


Antimicrobial Agents and Chemotherapy, April 2001, p. 1014-1021, Vol. 45, No. 4
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.4.1014-1021.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2001 by the American Society for Microbiology. All rights reserved.